Comparative study on pharmacokinetics and toxicity of intravitreal and sub-Tenon injection of triamcinolone acetonide in ocular tissues

被引:3
|
作者
Arie, Yuko [1 ]
Miyai, Hiroko [1 ]
Suzuki, Ayako [1 ]
Okabe, Takeshi [1 ]
Takashima, Mitsuyo [1 ]
Takata, Mayumi [1 ]
Kurasawa, Takashi [1 ]
Ito, Masaki [1 ]
Arakawa, Reijiro [1 ]
Ogura, Yuichiro [2 ]
Naito, Akira [1 ]
机构
[1] Wakamoto Pharmaceut Corp Ltd, Sagami Res Labs, Oi, Kanagawa 2580018, Japan
[2] Nagoya City Univ, Grad Sch Med Sci, Dept Ophthalmol & Visual Sci, Nagoya, Aichi 4678601, Japan
关键词
corticosteroid(s); pharmacokinetics; injection; ophthalmic drug delivery; toxicity; DIABETIC MACULAR EDEMA; SUBTENON; ENDOPHTHALMITIS; VITRECTOMY; DELIVERY; BARRIERS; SURGERY; SAFETY; MODEL;
D O I
10.18240/ijo.2020.12.04
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
AIM: To compare the differences in kinetics, distribution, and toxicity of triamcinolone acetonide (TA) between the injection methods, sub-Tenon and intravitreal injections in rabbit ocular tissues. METHODS: TA was injected into the vitreous or the sub-Tenon in rabbits. For pharmacokinetic study, rabbits were sacrificed periodically and then TA in blood and ocular tissues (retina/choroids, vitreous, and aqueous humor) were measured over 91d. For toxicological study, clinical signs, slit-lamp microscopic examination, ophthalmological test were performed. The eyeballs and surrounding tissues were collected and fixed with glutaraldehyde-formalin solution, and then paraffin embedded for histological investigation. RESULTS: Higher levels of TA were distributed in the intraocular tissues when injected into the vitreous compared to the sub-Tenon. Conversely, TA level was remarkably lower in the rabbits which received intravitreal TA injections than those treated with sub-Tenon injection throughout the study period in plasma. Optical discharge probably caused by systemic circulation of TA was observed by receiving sub-Tenon TA injection. Meanwhile, technic-associated toxicological ocular symptoms and findings were more frequently observed in intravitreal injection than in sub-Tenon injection. CONCLUSION: There are significant differences in kinetics and distribution of TA in vitreous body, aqueous humor and plasma, between the two injection methods. Although further study is needed to explain the species difference between human and rabbit, it is assumed that the difference in the frequency of intraocular pressure elevation and cataract formation by TA between the two injection methods are directly related to the TA concentrations in aqueous humor and vitreous body in each injection methods. Systemic toxicity and technic-associated toxicity are also closely related to kinetics of TA in plasma and each injection method itself, respectively.
引用
收藏
页码:1864 / 1871
页数:8
相关论文
共 50 条
  • [21] Injection of triamcinolone acetonide into the posterior sub-tenon capsule for treatment of diabetic macular edema
    Toda, Junko
    Fukushima, Harumi
    Kato, Satoshi
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2007, 27 (06): : 764 - 769
  • [22] Trabeculectomy With or Without Intraoperative Sub-Tenon Injection of Triamcinolone Acetonide in Treating Secondary Glaucoma
    Yuki, Kenya
    Shiba, Daisuke
    Kimura, Itaru
    Ohtake, Yuichiro
    Tsubota, Kazuo
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2009, 147 (06) : 1055 - 1060
  • [23] Accidental Globe Perforation during Posterior Sub-Tenon's Injection of Triamcinolone Acetonide
    Singh, Simar Rajan
    Dogra, Mohit
    Singh, Ramandeep
    Dogra, Mangat Ram
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2019, 50 (07): : 466 - 467
  • [24] Evaluation of Sub-Tenon Triamcinolone Acetonide Injections in the Treatment of Scleritis
    Johnson, Keegan S.
    Chu, David S.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2010, 149 (01) : 77 - 81
  • [25] Pharmacokinetic Study of Vitreous and Serum Concentrations of Triamcinolone Acetonide After Posterior Sub-Tenon's Injection
    Kovacs, K. D.
    Quirk, M. T.
    Ceron, O. M.
    Silva, P. S.
    Singh, R. J.
    Gukasyan, H. J.
    Arroyo, J. G.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [26] Pharmacokinetic Study of Vitreous and Serum Concentrations of Triamcinolone Acetonide After Posterior Sub-Tenon's Injection
    Kovacs, Kyle
    Wagley, Sushant
    Quirk, Matthew T.
    Ceron, Olga M.
    Silva, Paolo A.
    Singh, Ravinder J.
    Gukasyan, Hovhannes J.
    Arroyo, Jorge G.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2012, 153 (05) : 939 - 948
  • [27] COMBINED INTRAVITREAL RANIBIZUMAB AND POSTERIOR SUB-TENON INJECTION OF TRIAMCINOLONE ACETONIDE FOR THE TREATMENT OF DIABETIC MACULAR EDEMA WITH SEROUS RETINAL DETACHMENT
    Ercalik, N. Y.
    Yenerel, N. M.
    Imamoglu, S.
    Kumral, E. T.
    Vural, E. T.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2015, 25 (03) : E26 - E26
  • [28] Intravitreal injection versus sub-Tenon's infusion of triamcinolone acetonide for refractory diabetic macular edema: A randomized clinical trial
    Bonini, MA
    Jorge, R
    Barbosa, JC
    Calucci, D
    Cardillo, JA
    Costa, RA
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46 (10) : 3845 - 3849
  • [29] Effect of intravitreal or sub-tenon triamcinolone acetonide injection at completion of vitrectomy on peripheral retinochoroidal thickness in eyes with proliferative diabetic retinopathy
    Fujiwara, Yoshito
    Iwase, Takeshi
    Yamamoto, Kentaro
    Ueno, Yoshitaka
    Ra, Eimei
    Terasaki, Hiroko
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [30] Comparison between intravitreal bevacizumab and posterior sub-tenon injection of triamcinolone acetonide in macular edema secondary to retinal vein occlusion
    Tsai, Meng-Ju
    Hsieh, Yi-Ting
    Peng, Yi-Jie
    CLINICAL OPHTHALMOLOGY, 2018, 12 : 1229 - 1235